- Home
- FBRX vs GPMT Comparison
FBRX vs GPMT Comparison
Compare FBRX & GPMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBRX
- GPMT
- Stock Information
- Founded
- FBRX N/A
- GPMT 2015
- Country
- FBRX United States
- GPMT United States
- Employees
- FBRX N/A
- GPMT N/A
- Industry
- FBRX Biotechnology: Pharmaceutical Preparations
- GPMT Real Estate Investment Trusts
- Sector
- FBRX Health Care
- GPMT Real Estate
- Exchange
- FBRX Nasdaq
- GPMT Nasdaq
- Market Cap
- FBRX 125.9M
- GPMT 148.4M
- IPO Year
- FBRX N/A
- GPMT 2017
- Fundamental
- Price
- FBRX $15.35
- GPMT $3.00
- Analyst Decision
- FBRX Strong Buy
- GPMT Buy
- Analyst Count
- FBRX 4
- GPMT 5
- Target Price
- FBRX $77.58
- GPMT $4.58
- AVG Volume (30 Days)
- FBRX 61.1K
- GPMT 474.1K
- Earning Date
- FBRX 11-14-2024
- GPMT 02-12-2025
- Dividend Yield
- FBRX N/A
- GPMT 10.24%
- EPS Growth
- FBRX N/A
- GPMT N/A
- EPS
- FBRX N/A
- GPMT N/A
- Revenue
- FBRX N/A
- GPMT N/A
- Revenue This Year
- FBRX N/A
- GPMT N/A
- Revenue Next Year
- FBRX N/A
- GPMT $10.18
- P/E Ratio
- FBRX N/A
- GPMT N/A
- Revenue Growth
- FBRX N/A
- GPMT N/A
- 52 Week Low
- FBRX $4.11
- GPMT $2.46
- 52 Week High
- FBRX $28.68
- GPMT $6.13
- Technical
- Relative Strength Index (RSI)
- FBRX 41.80
- GPMT 50.03
- Support Level
- FBRX $14.66
- GPMT $2.87
- Resistance Level
- FBRX $17.00
- GPMT $3.01
- Average True Range (ATR)
- FBRX 2.62
- GPMT 0.11
- MACD
- FBRX -0.86
- GPMT 0.04
- Stochastic Oscillator
- FBRX 13.83
- GPMT 85.00
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).
About GPMT Granite Point Mortgage Trust Inc.
Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning, and repurposing of the property.